Cardiomyocytes

Stem cells differentiated into cardiomyocytes are used to screen early for potential toxicological effects of drugs, thus helping to avoid investment in development of drugs which will fail in clinical trials due to cardiac toxicity.

• Poster: Multi-parametric assessment of compound-induced pro-arrhythmic effects in human iPSC-derived cardiomyocytes
• Assaying cardiotoxicity with ImageXpress high-content screening systems
• High throughput cardiotoxicity assays using stem cell-derived cardiomyocytes
• Multiplexed automated imaging assays for compound testing using iPSC-derived cell models
• Paper: In vitro cardiotoxicity assessment of environmental chemicals using an organotypic human iPSC-derived model